BioCentury
ARTICLE | Clinical News

Viaskin rPT: Phase I started

September 12, 2016 7:00 AM UTC

DBV began a double-blind, placebo-controlled, dose-escalation, Swiss Phase I trial to evaluate two 48-hour applications of 25 and 50 ug Viaskin rPT given 2 weeks apart in about 60 healthy adults. Subj...